Phase 2 Fruquintinib Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 2
A Phase 2 Trial of Fruquintinib and Tislelizumab in ctDNA-defined Minimal Residual Disease in Colorectal Cancer After Completion of Adjuvant Chemotherapy
Colorectal, CancerMinimal Residual DiseasectDNA+3 more
M.D. Anderson Cancer Center20 enrolled1 locationNCT07136077
Recruiting
Phase 1Phase 2
Fruquintinib Combined With Trastuzumab and XELOX as First-line Treatment in Patients With HER2-positive Advanced Gastric Cancer
Gastric (Stomach) CancerGastric AdenocarcinomaGEJ Adenocarcinoma+3 more
Henan Cancer Hospital45 enrolled1 locationNCT07334431
Recruiting
Phase 2
The Safety and Efficacy of Cetuximab Beta Plus Fruquintinib With or Without Immune Checkpoint Inhibitorrs in First-line Treatment of RAS/BRAF Wild Type Unresectable Metastatic Colorectal Cancer
Colorectal NeoplasmsBRAFCetuximab+2 more
Zhejiang University70 enrolled1 locationNCT07257653
Recruiting
Phase 2
Fruquintinib Plus S-1 and Raltitrexed (RSF) for MCRC
FruquintinibS-1Raltitrexed
Meng Qiu66 enrolled2 locationsNCT06427005